Aurobindo Pharma Limited (AUROPHARMA) — Cash Flow Reinvestment Rate
Aurobindo Pharma Limited (AUROPHARMA) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting Rs13.63 Billion (capex Rs13.63 Billion ) from operating cash flow of Rs28.85 Billion. Check AUROPHARMA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aurobindo Pharma Limited Cash Flow Reinvestment Rate (2004–2026)
Historical reinvestment intensity for Aurobindo Pharma Limited across 22 annual periods. Explore Aurobindo Pharma Limited long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Aurobindo Pharma Limited (2004–2026)
Year-by-year capital reinvestment analysis for Aurobindo Pharma Limited. For live market cap and broader valuation context, see AUROPHARMA company net worth.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.68x | Rs37.68 Billion | Rs55.13 Billion | Rs26.86 Billion | ▼ -30.2% |
| 2025 | 0.98x | Rs38.44 Billion | Rs39.25 Billion | Rs19.68 Billion | ▼ -69.5% |
| 2024 | 3.21x | Rs78.17 Billion | Rs24.35 Billion | Rs35.62 Billion | ▲ +14.4% |
| 2023 | 2.81x | Rs66.98 Billion | Rs23.87 Billion | Rs27.20 Billion | ▲ +351.9% |
| 2022 | 0.62x | Rs31.16 Billion | Rs50.16 Billion | Rs27.05 Billion | ▼ -12.7% |
| 2021 | 0.71x | Rs23.68 Billion | Rs33.29 Billion | Rs18.74 Billion | ▲ +92.6% |
| 2020 | 0.37x | Rs16.19 Billion | Rs43.81 Billion | Rs14.31 Billion | ▼ -62.6% |
| 2019 | 0.99x | Rs16.31 Billion | Rs16.51 Billion | Rs15.59 Billion | ▲ +20.9% |
| 2018 | 0.82x | Rs15.98 Billion | Rs19.55 Billion | Rs15.30 Billion | ▲ +47.9% |
| 2017 | 0.55x | Rs18.12 Billion | Rs32.79 Billion | Rs16.94 Billion | ▼ -50.9% |
| 2016 | 1.12x | Rs15.97 Billion | Rs14.20 Billion | Rs15.66 Billion | ▲ +76.6% |
| 2015 | 0.64x | Rs7.88 Billion | Rs12.37 Billion | Rs7.68 Billion | ▼ -49.5% |
| 2014 | 1.26x | Rs8.15 Billion | Rs6.46 Billion | Rs3.90 Billion | ▲ +26.8% |
| 2013 | 0.99x | Rs2.73 Billion | Rs2.75 Billion | Rs2.73 Billion | ▼ -43.2% |
| 2012 | 1.75x | Rs5.71 Billion | Rs3.26 Billion | Rs5.71 Billion | ▼ -18.0% |
| 2011 | 2.14x | Rs7.16 Billion | Rs3.35 Billion | Rs7.16 Billion | ▲ +118.1% |
| 2010 | 0.98x | Rs4.20 Billion | Rs4.29 Billion | Rs4.20 Billion | ▼ -72.4% |
| 2009 | 3.55x | Rs4.83 Billion | Rs1.36 Billion | Rs4.83 Billion | ▲ +128.8% |
| 2008 | 1.55x | Rs2.46 Billion | Rs1.59 Billion | Rs2.46 Billion | ▼ -91.3% |
| 2007 | 17.79x | Rs3.32 Billion | Rs186.50 Million | Rs3.32 Billion | ▲ +560.9% |
| 2005 | 2.69x | Rs3.29 Billion | Rs1.22 Billion | Rs3.29 Billion | ▼ -73.3% |
| 2004 | 10.08x | Rs2.00 Billion | Rs198.90 Million | Rs2.00 Billion | — |